267 related articles for article (PubMed ID: 31817853)
41. Emerging molecular subtypes and therapies in acute lymphoblastic leukemia.
Davis K; Sheikh T; Aggarwal N
Semin Diagn Pathol; 2023 May; 40(3):202-215. PubMed ID: 37120350
[TBL] [Abstract][Full Text] [Related]
42. Tumor suppressor BTG1 limits activation of BCL6 expression downstream of ETV6-RUNX1.
Tijchon E; van Emst L; Yuniati L; van Ingen Schenau D; Gerritsen M; van der Meer LT; Williams O; Hoogerbrugge PM; Scheijen B; van Leeuwen FN
Exp Hematol; 2018 Apr; 60():57-62.e3. PubMed ID: 29408281
[TBL] [Abstract][Full Text] [Related]
43. Reduction of RUNX1 transcription factor activity by a CBFA2T3-mimicking peptide: application to B cell precursor acute lymphoblastic leukemia.
Jakobczyk H; Debaize L; Soubise B; Avner S; Rouger-Gaudichon J; Commet S; Jiang Y; Sérandour AA; Rio AG; Carroll JS; Wichmann C; Lie-A-Ling M; Lacaud G; Corcos L; Salbert G; Galibert MD; Gandemer V; Troadec MB
J Hematol Oncol; 2021 Mar; 14(1):47. PubMed ID: 33743795
[TBL] [Abstract][Full Text] [Related]
44. ETV6/RUNX1-positive relapses evolve from an ancestral clone and frequently acquire deletions of genes implicated in glucocorticoid signaling.
Kuster L; Grausenburger R; Fuka G; Kaindl U; Krapf G; Inthal A; Mann G; Kauer M; Rainer J; Kofler R; Hall A; Metzler M; Meyer LH; Meyer C; Harbott J; Marschalek R; Strehl S; Haas OA; Panzer-Grümayer R
Blood; 2011 Mar; 117(9):2658-67. PubMed ID: 21224468
[TBL] [Abstract][Full Text] [Related]
45. ETV6/RUNX1 fusion lacking prognostic effect in pediatric patients with acute lymphoblastic leukemia.
Zen PR; Capra ME; Silla LM; Loss JF; Fernandes MS; Jacques SM; Paskulin GA
Cancer Genet Cytogenet; 2009 Jan; 188(2):112-7. PubMed ID: 19100516
[TBL] [Abstract][Full Text] [Related]
46. Differing Outcomes of Patients with High Hyperdiploidy and ETV6-RUNX1 Rearrangement in Korean Pediatric Precursor B Cell Acute Lymphoblastic Leukemia.
Lee JW; Kim S; Jang PS; Chung NG; Cho B
Cancer Res Treat; 2021 Apr; 53(2):567-575. PubMed ID: 33070555
[TBL] [Abstract][Full Text] [Related]
47. ETV6/RUNX1 rearrangement in childhood B-precursor acute lymphoblastic leukemia with normal karyotypes or without cytogenetic results.
Alvarez Y; Gaitán S; Perez A; Bastida P; Ortega JJ; Dastugue N; Robert A; Aventín A; Badell I; Guitart M; Melo M; Caballín MR; Coll MD
Cancer Genet Cytogenet; 2004 Jul; 152(1):77-80. PubMed ID: 15193447
[TBL] [Abstract][Full Text] [Related]
48. Rare concomitance of ETV6::RUNX1 and BCR::ABL1p210 in a child diagnosed with B-cell precursor acute lymphoblastic leukemia.
Barbosa TC; Oliveira E; Blunck CB; Maciel A; Bastos A; Bouzada H; Rouxinol ST; Mansur MB; Costa ES; Almeida CW; Emerenciano M
Cancer Genet; 2023 Aug; 276-277():40-42. PubMed ID: 37480760
[No Abstract] [Full Text] [Related]
49. A Human IPS Model Implicates Embryonic B-Myeloid Fate Restriction as Developmental Susceptibility to B Acute Lymphoblastic Leukemia-Associated ETV6-RUNX1.
Böiers C; Richardson SE; Laycock E; Zriwil A; Turati VA; Brown J; Wray JP; Wang D; James C; Herrero J; Sitnicka E; Karlsson S; Smith AJH; Jacobsen SEW; Enver T
Dev Cell; 2018 Feb; 44(3):362-377.e7. PubMed ID: 29290585
[TBL] [Abstract][Full Text] [Related]
50. Abnormalities of the der(12)t(12;21) in ETV6-RUNX1 acute lymphoblastic leukemia.
Al-Shehhi H; Konn ZJ; Schwab CJ; Erhorn A; Barber KE; Wright SL; Gabriel AS; Harrison CJ; Moorman AV
Genes Chromosomes Cancer; 2013 Feb; 52(2):202-13. PubMed ID: 23077088
[TBL] [Abstract][Full Text] [Related]
51.
Montaño A; Ordoñez JL; Alonso-Pérez V; Hernández-Sánchez J; Santos S; González T; Benito R; García-Tuñón I; Hernández-Rivas JM
Cells; 2020 Jan; 9(1):. PubMed ID: 31952221
[TBL] [Abstract][Full Text] [Related]
52. Clonal origins of relapse in ETV6-RUNX1 acute lymphoblastic leukemia.
van Delft FW; Horsley S; Colman S; Anderson K; Bateman C; Kempski H; Zuna J; Eckert C; Saha V; Kearney L; Ford A; Greaves M
Blood; 2011 Jun; 117(23):6247-54. PubMed ID: 21482711
[TBL] [Abstract][Full Text] [Related]
53. Proapoptotic and immunomodulatory effects of SYK inhibitor entospletinib in combination with obinutuzumab in patients with chronic lymphocytic leukaemia.
Lam V; Best S; Kittai A; Orand K; Spurgeon SE; Liu T; Danilov AV
Br J Clin Pharmacol; 2022 Feb; 88(2):836-841. PubMed ID: 34196037
[TBL] [Abstract][Full Text] [Related]
54. Deregulated Syk inhibits differentiation and induces growth factor-independent proliferation of pre-B cells.
Wossning T; Herzog S; Köhler F; Meixlsperger S; Kulathu Y; Mittler G; Abe A; Fuchs U; Borkhardt A; Jumaa H
J Exp Med; 2006 Dec; 203(13):2829-40. PubMed ID: 17130299
[TBL] [Abstract][Full Text] [Related]
55. [Clinical features and prognosis of ETV6-RUNX1-positive childhood B-precursor acute lymphocyte leukemia].
Zheng YZ; Pan LL; Li J; Chen ZS; Hua XL; Le SH; Zheng H; Chen C; Hu JD
Zhonghua Xue Ye Xue Za Zhi; 2021 Jan; 42(1):45-51. PubMed ID: 33677868
[No Abstract] [Full Text] [Related]
56. Clonal variation of the immunogenotype in relapsed ETV6/RUNX1-positive acute lymphoblastic leukemia indicates subclone formation during early stages of leukemia development.
Peham M; Konrad M; Harbott J; König M; Haas OA; Panzer-Grümayer ER
Genes Chromosomes Cancer; 2004 Feb; 39(2):156-60. PubMed ID: 14695996
[TBL] [Abstract][Full Text] [Related]
57. Preserved global histone H4 acetylation linked to ETV6-RUNX1 fusion and PAX5 deletions is associated with favorable outcome in pediatric B-cell progenitor acute lymphoblastic leukemia.
Janczar K; Janczar S; Pastorczak A; Mycko K; Paige AJ; Zalewska-Szewczyk B; Wagrowska-Danilewicz M; Danilewicz M; Mlynarski W
Leuk Res; 2015 Dec; 39(12):1455-61. PubMed ID: 26520622
[TBL] [Abstract][Full Text] [Related]
58. Anti-adult T‑cell leukemia/lymphoma activity of cerdulatinib, a dual SYK/JAK kinase inhibitor.
Ishikawa C; Senba M; Mori N
Int J Oncol; 2018 Oct; 53(4):1681-1690. PubMed ID: 30066853
[TBL] [Abstract][Full Text] [Related]
59. Cytoskeletal regulatory gene expression and migratory properties of B-cell progenitors are affected by the ETV6-RUNX1 rearrangement.
Palmi C; Fazio G; Savino AM; Procter J; Howell L; Cazzaniga V; Vieri M; Longinotti G; Brunati I; Andrè V; Della Mina P; Villa A; Greaves M; Biondi A; D'Amico G; Ford A; Cazzaniga G
Mol Cancer Res; 2014 Dec; 12(12):1796-806. PubMed ID: 25061103
[TBL] [Abstract][Full Text] [Related]
60. Resistance Mechanisms to SYK Inhibition in Acute Myeloid Leukemia.
Cremer A; Ellegast JM; Alexe G; Frank ES; Ross L; Chu SH; Pikman Y; Robichaud A; Goodale A; Häupl B; Mohr S; Rao AV; Walker AR; Blachly JS; Piccioni F; Armstrong SA; Byrd JC; Oellerich T; Stegmaier K
Cancer Discov; 2020 Feb; 10(2):214-231. PubMed ID: 31771968
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
